Albuterol Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Alerts
• Clinical Trials
• Forums

Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD
Condition:   COPD Exacerbation Interventions:   Drug: Revefenacin (YUPELRI)& Formoterol (Perforomist);   Drug: Albuterol Inhalation Aerosol (short-acting beta-agonists)& Ipratropium Aerosol (short-acting anticholinergic) Sponsors:   University of Tennessee Graduate School of Medicine;   Mylan Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2020 Category: Research Source Type: clinical trials